Press release
Global Orphan Drugs Market 2018 - Celgene, Roche, Pfizer, Sanofi
Global Orphan Drugs Market
Get Free Sample Copy of Report Here: http://bit.ly/2TVTFWT
Scope of the Report:
This report focuses on the Orphan Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
High unmet needs are one of the primary drivers of market growth. The need for the development of effective drugs with lesser side-effects is rapidly rising in the market.
Moreover, the initiatives from the governments of various countries across the globe towards R&D activities and numerous marketing approvals of these drugs have also influenced the orphan drugs market growth. Furthermore, the rising occurrences of rare diseases with the mounting awareness among the population and larger life expectancy numbers have accelerated the global orphan drug market to grow higher.
The worldwide market for Orphan Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2018.
Market Segment by Manufacturers, this report covers
Novartis
Bristol-Myers Squibb
Celgene
Roche
Pfizer
Sanofi
Alexion Pharmaceuticals
Eli Lilly
Novo Nordisk
AstraZeneca
Eisai
Daiichi Sankyo
Bayer
GlaxoSmithKline
Merck
Johnson & Johnson
Biogen
Shire
Amgen
Inquire Before Buying @ http://bit.ly/2CmJqDQ
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
There are 15 Chapters to deeply display the global Orphan Drugs market.
Chapter 1, to describe Orphan Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Orphan Drugs, with sales, revenue, and price of Orphan Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Orphan Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Orphan Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Orphan Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
About Us
“Apex Market Reports” offers elevating market research globally. We have collection of various syndicated reports of different categories. “Apex Market Reports” provides you to best services, weather you’re searching for new trends in market or competitive scenario in emerging market.
Customers can buys different reports across various categories such as Chemical and Material, Biotechnology, Healthcare, Food and beverages, Automobile and various sectors. Our Website offers safe and secure online ordering experience, convenient payment options.
Contact Us
Frank Valadez
S no. 72/1/A/6, Floor No. 1,
Harikrishna Building, Samarth Nagar,
New Sanghvi, Pune-411027 India.
Phone: +91-8149441100
Email id - sales@apexmarketreports.com
Website - www.apexmarketreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Orphan Drugs Market 2018 - Celgene, Roche, Pfizer, Sanofi here
News-ID: 1502503 • Views: …
More Releases from Apex Market Reports
Global EMV Payment Card Market (2021 to 2026)- Industry Trends, Share, Size, Gro …
Global EMV Payment Card Market 2021-2026 issued by Pro Data Inteligence provides a detailed analysis of the dynamic of the market with extensive focus on secondary research. The report sheds light on the current situation of the market size, share, demand, development patterns, and forecast in the coming years.
This report consist several changes as here we also cover impact of COVID-19 on Global market
The report Global EMV Payment Card Market…
Contactless IC Cards Industry 2021 Analysis & Forecast To 2027 By Key Players, S …
Global Contactless IC Cards Market 2021-2026 issued by Pro Data Inteligence provides a detailed analysis of the dynamic of the market with extensive focus on secondary research. The report sheds light on the current situation of the market size, share, demand, development patterns, and forecast in the coming years.
This report consist several changes as here we also cover impact of COVID-19 on Global market
The report Global Contactless IC Cards Market…
Global Smart IC Card Market (2021 to 2026)- Industry Trends, Share, Size, Growth …
Global Smart IC Card Market 2021-2026 issued by Pro Data Inteligence provides a detailed analysis of the dynamic of the market with extensive focus on secondary research. The report sheds light on the current situation of the market size, share, demand, development patterns, and forecast in the coming years.
This report consist several changes as here we also cover impact of COVID-19 on Global market
The report Global Smart IC Card Market…
Smart Cards In Healthcare Industry 2021 Analysis & Forecast To 2027 By Key Playe …
Global Smart Cards In Healthcare Market 2021-2026 issued by Pro Data Inteligence provides a detailed analysis of the dynamic of the market with extensive focus on secondary research. The report sheds light on the current situation of the market size, share, demand, development patterns, and forecast in the coming years.
This report consist several changes as here we also cover impact of COVID-19 on Global market
The report Global Smart Cards In…
More Releases for Orphan
Potential Opportunities of Orphan Drugs Market
As per Fortune Business Insights, the North America Orphan Drugs Market was worth US$ 67,136.0 Mn in 2017 and will continue to rise at a steady pace until 2025. This is mainly ascribable to the rising awareness among people regarding the use of novel drugs. In addition to this, North America is expected to offer attractive growth opportunities on the back of recent FDA approvals on the development of orphan…
Orphan Drug Pipeline & Regulatory Insight 2025
Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights:
Global Orphan Drug Market Overview: US$ 260 Billion Opportunity
Global Orphan Drug market by Segment
Regulatory Landscape: USA, Europe & Asia
Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia
Global Orphan Drug Clinical Pipeline Insight: 973 Drugs
Marketed Orphan Drug Clinical Insight: 366 Drugs
The global orphan drug market opportunity is expected to surpass US$ 260 Billion by 2025 as per…
Orphan Drugs for Cancer Pipeline Analysis
A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed…
US Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.…
Europe Orphan Drugs Pipeline Analysis
“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug…
Global Orphan Drug Pipeline Analysis
In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the…
